
What We're Reading: ADHD Medication Access Concerns; 2023 US Health Care Spend; Legislation Introduced to Reform PA
The arrests of the founders of Done Global, a telehealth company that provides attention-deficit/hyperactivity disorder (ADHD) medication to adults, for allegedly providing prescriptions to unqualified patients and defrauding the government have raised concerns about future access to these medications; US health care spending rose to $4.8 trillion in 2023; bipartisan legislation has been introduced to reform prior authorization with Medicare Advantage.
Arrests Raise Concerns About Access to ADHD Medication
The Justice Department has arrested the founders of Done Global, a telehealth company that provides adults with medication to treat their attention-deficit-hyperactivity disorder (ADHD). They have been accused of allegedly providing prescriptions to unqualified patients and defrauding the government, according to
US Spends $4.8 Trillion on Health Care in 2023
In the US, health care spending rose 7.5% in 2023 to $4.8 trillion, exceeding the growth rate of the gross domestic product (GDP), reports
Legislation to Reform Prior Authorization Introduced, Bipartisan Support
Senator Roger Marshall (R-Kansas) and Representative Suzan DelBene (D-Washington) have reintroduced a bill that aims to streamline the use of prior authorization for Medicare Advantage, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.